Marilyn S. Campbell

Marilyn S. Campbell

Auto-generated profile, based on publicly available information

Marilyn S. Campbell

Department of Kinesiology and Health Promotion, University of Kentucky, Lexington, Kentucky, USA

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
17 November 2020 in British Journal of Nutrition
Verified
Journal Article
Closed access
PDF file
OAOmid Asbaghi
Omid Asbaghi
AHAmir Hadi
Amir Hadi
MCMarilyn S. Campbell
Marilyn S. Campbell
KVKamesh Venkatakrishnan
Kamesh Venkatakrishnan
EGEhsan Ghaedi
Ehsan Ghaedi
Evidence suggests that eating nuts may reduce the risk of CVD. This study was intended to pool the data of all randomised controlled trials (RCT) available to determine if pistachios confer a beneficial effect on anthropometric indices, inflammatory markers, endothelial dysfunction and blood pressure. Without language restriction, PubMed, Scopus, Cochrane Library and Web of Science were searched for articles published from the earliest records to June 2019 investigating the effect of pistachio consumption on inflammation, endothelial dysfunction and hypertension. Mean difference (MD) was pooled using a random effects model. The Cochrane risk of bias tool was used to evaluate the quality of the studies. The meta-analysis of thirteen RCT with 563 participants indicated that pistachio consumption significantly decreased systolic blood pressure (SBP) (MD: −2·12 mmHg, 95 % CI −3·65, −0·59, P = 0·007), whereas changes in flow-mediated dilation (MD: 0·94 %, 95 % CI −0·99, 2·86, P = 0·813), diastolic blood pressure (MD: 0·32 mmHg, 95 % CI −1·37, 2·02, P = 0·707), C-reactive protein (MD: 0·00 mg/l, 95 % CI −0·21, 0·23, P = 0·942), TNF-α (MD: −0·09 pg/ml, 95 % CI −0·38, 0·20, P = 0·541), body weight (MD: 0·09 kg, 95 % CI −0·38, 0·69, P = 0·697), BMI (MD: 0·07 kg/m2, 95 % CI −0·16, 0·31, P = 0·553) and waist circumference (MD: 0·77 cm, 95 % CI −0·09, 1·64, P = 0·140) were not statistically significant. This systematic review and meta-analysis suggested the efficacy of pistachio consumption to reduce SBP levels. However, further large-scale studies are needed to confirm these results.

1 March 2021 in Complementary Therapies in Medicine
Verified
Journal Article
Open access
MMMozhgan Moradi
Mozhgan Moradi
GSGhazale Sohrabi
Ghazale Sohrabi
MGMojgan Golbidi
Mojgan Golbidi
SYSamira Yarmohammadi
Samira Yarmohammadi
NHNiloofar Hemati
Niloofar Hemati
MFMohammad Hosein Farzaei
Mohammad Hosein Farzaei
Clinical trials considering the effects of artichoke supplementation on blood pressure have yielded different and contradictory outcomes. Thus, a systematic review and meta-analysis were performed to assess effects of artichoke administration on blood pressure. Related studies were detected by searching the Cochrane Library, PubMed, Embase and Scopus databases up to 15 March 2020. Weighted Mean Differences (WMD) were pooled using a random-effects model. Heterogeneity, sensitivity analyses, and publication bias were evaluated using standard methods. Pooled analysis of eight randomized controlled trials revealed that artichoke supplementation did not have an effect on systolic blood pressure (SBP), (WMD: -0.77 mmHg, 95 % CI: -2.76 to 1.22) or diastolic blood pressure (DBP) (WMD: -0.11 mmHg, 95 % CI: -1.72 to 1.50) when compared to the placebo group. However, subgroup analyses based on health status suggested that artichoke administration among hypertensive patients may significantly reduce SBP (WMD: -3.19 mmHg, 95 % CI: -3.32 to -3.06) and DBP (WMD: -2.33 mmHg, 95 % CI: -2.23 to -2.43), but no such reduction was found in NAFLD patients. Furthermore, our results indicated that artichoke supplementation for 12 weeks led to a significantly decreased DBP (WMD: -2.33 mmHg, 95 % CI: -2.43 to -2.23), but 8 weeks of intervention did not (WMD: 0.80 mmHg, 95 % CI: -1.06 to 2.66). Artichoke supplementation may potentially lead to SBP and DBP reduction in hypertensive patients. In addition, artichoke supplementation for 12 weeks may significantly improve DBP.

29 August 2017 in American Journal of Health Promotion
Verified
Journal Article
Closed access
MMM. Ryan Mason
M. Ryan Mason
MIMelinda Ickes
Melinda Ickes
MCMarilyn S. Campbell
Marilyn S. Campbell
LBLance Bollinger
Lance Bollinger
To determine the efficacy of an incentivized workplace PA intervention. Retrospective cohort design. Large southeastern university. Of the 16 588 eligible employees working ≥8 h/wk, 6246 (37.6%) participated and 2206 (13.3%) were included in data analysis. Six-week PA intervention with tiered incentives (value: $10.50-$29.00). Steps/day measured via consumer-grade PA monitors for 1-week pre-, 6-weeks during, and 1-week postintervention. Participants were grouped by preintervention PA into 4 groups: <6000 (I); 6000 to 7999 (II); 8000 to 9999 (III); and ≥10 000 (IV) steps/d (n = 481, 540, 485, and 700, respectively) in accordance with the tiered incentive schedule. Statistical comparisons were made by repeated-measures analysis of variance. During the intervention, participants achieving ≥10 000 steps/d increased by 60%. Groups I, II, and III significantly increased steps/day during the intervention (46%, 24%, and 11%, respectively), which was partially maintained in groups I and II 1-week postintervention. Group IV did not increase steps/day during the intervention and significantly decreased steps/day 1-week postintervention. The estimated cost per participant of this intervention increased with from group I ($55.41) to IV ($71.90). An incentivized, workplace PA intervention preferentially increases PA and is most cost-effective among university employees with low initial PA who may benefit substantially from increased levels of PA.

1 November 2019 in Current Opinion in Clinical Nutrition and Metabolic Care
Verified
Journal Article
Closed access
BFBrad Fleenor
Brad Fleenor
NCNicholas A. Carlini
Nicholas A. Carlini
MCMarilyn S. Campbell
Marilyn S. Campbell
The purpose of this review is to provide a concise overview of the polyphenol curcumin for improving arterial health, specifically endothelial function and arterial stiffness, to reduce cardiovascular disease (CVD) risk and to highlight potential mechanisms of action by which curcumin may improve artery function. The primary findings of this review support the notion for curcumin to improve arterial health both with aging and obesity. There are few clinical trials on curcumin, and those that currently exist are small in scale but provide evidence for curcumin to improve endothelial function in older adults and reduce arterial stiffness in young, obese men. The antioxidant and anti-inflammatory properties of curcumin appear to be important targets of curcumin that are related to improved arterial health. Mechanistic studies have revealed superoxide dismutase, heme oxygenase-1 and nuclear factor erythroid 2-related factor 2 as emerging targets for the beneficial effects of curcumin on the vasculature. In summary, the efficacy of curcumin for improving arterial function is promising in the limited number of clinical studies performed to date. Still, much investigation is needed to elucidate the effectiveness of curcumin for improving arterial health to lower CVD risk.

18 August 2026 in Health Promotion Practice
Verified
Journal Article
Closed access
MNMarilyn S. Nehls
Marilyn S. Nehls
ACAdrianne N. Caudill
Adrianne N. Caudill
DFDavid W. Fardo
David W. Fardo
CDCarrie D. Davidson
Carrie D. Davidson
MRMartha C. Riddell
Martha C. Riddell
RIRichard C. Ingram
Richard C. Ingram
Worksite wellness programs are popular employer offerings as of the last few decades. The COVID-19 pandemic caused major shifts in behavior since these programs were implemented. The purpose of this study was to understand how the COVID-19 pandemic affected participation in a worksite wellness program. This study is a secondary analysis of a university worksite wellness program that compared monthly participation in 2019 (pre-pandemic) versus 2020 (after the onset of the COVID-19 pandemic). The main outcome measures included participation within two offerings (single-visit or ongoing programming) for each of the three arms (MoveWell, EatWell, and BeWell) of the worksite wellness program. Statistical analyses included the Shapiro–Wilk test for data normality, paired t -tests for year-to-year differences in overall participation, and Wald confidence intervals for year-to-year differences in specific offerings. Overall, participation in the worksite wellness program decreased during the pandemic when compared with participation of the previous year ( p = .016). Participation in the BeWell and EatWell offerings had no significant change from 2019 to 2020. Among the MoveWell offerings, the group fitness classes (ongoing programming) were the only worksite wellness offering that showed decreased participation. Predictably, overall participation in a worksite wellness program decreased while employees were not physically in their workplace. However, it is noteworthy during the pandemic that employees were still participating in EatWell and BeWell programming such that participation was not significantly different from 2019. The results from this study could potentially be used to inform worksite wellness programming in future pandemics or other public health emergencies.

30 July 2023
Verified
Conference Paper
Open access
PDF file
JFJ Fraser
J Fraser
JFJ Frank
J Frank
ACA Chen
A Chen
MCM Campbell
M Campbell
LWL Wise
L Wise
JLJ Lee
J Lee
Introduction Viz.ai is a mobile triage tool for rapid identification and transfer of cerebrovascular emergencies. Viz.ai facilitates interhospital communication and data tracking. Our Comprehensive Stroke Center (CSC), located in a metropolitan area, interacts with many Viz.ai spoke hospitals in both metropolitan and rural areas of our state. There are known health disparities in rural communities throughout the United States. Using data from Viz.ai, we aimed to evaluate incidence of stroke activations and thrombectomy activations, comparing referring Primary Stroke Centers from rural and metropolitan communities. Methods Beginning in 2020, we utilized Viz.ai to triage stroke patients from the Primary Stroke Centers (PSCs) that refer complex stroke patients only to our CSC. Using data collected from January, 2022 to February, 2023, we evaluated the number of stroke activations (CT-angiograms performed to evaluate for stroke), and the number of thrombectomy alerts (artificial intelligence alert on Viz.ai). Using 2020 Census data, we calculated the ‘at-risk’ population for each referring hospitals as the total population of the hospital’s county and the counties immediate adjacent to them. We calculated and compared annualized per capita incidences of stroke activations and thrombectomy activations, comparing metropolitan to rural communities. Results During the study period, the metropolitan PSC had 298 stroke activations and 29 thrombectomy activations with an at-risk population of 192,644. One rural PSCs had 552 stroke activations, 38 thrombectomy alerts, with an at-risk population of 259,365, while the other had 501 stroke activations, 34 thrombectomy alerts, and an at-risk population of 199,744. Accounting for annualization and population density, this yielded a per capita incidence of stroke activation at the metropolitan PSC of 143 per 100,000, compared to an incidence at the rural PSCs of 232 per 100,000 and 234 per 100,000; compared to the metropolitan PSC, incidence of activations at the rural PSCs were both significantly higher (p<0.0001). The annualized per capita incidence of thrombectomy alerts was 3.4 per 100,000 at the metropolitan center, compared to 8.0 per 100,000 at one rural PSC and 4.6 per 100,000 at the other rural PSC. These trended toward but did not reach statistically significant differences (p 0.06 and 0.68 respective). Conclusion Compared to a metropolitan PSC in our network, two rural PSCs had significantly higher per capita incidence of stroke activations. There was a trend toward higher per capita thrombectomy alerts as well. Given the known health disparities in rural regions of the US, these findings provide clear confirmation of the importance of stroke care protocols in rural areas, and the value of rapid identification and triage for rural communities. Our future studies will examine more detailed patient-specific factors based on geographic region. Disclosures J. Fraser: None. J. Frank: None. A. Chen: None. M. Campbell: None. L. Wise: None. B. Krein: None. R. Silvernail: None. D. Dornbos: None. S. Pahwa: None. J. Lee: None.